Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Congressional Budget Office
Regulatory
Orphan drugs' price negotiation exemption to cost Medicare $8.8B
The OBBBA's expanded criteria for orphan drugs exempt from Medicare's drug price negotiation will have a greater hit than previously estimated.
Dave Muoio
Oct 21, 2025 3:39pm
Delaying ACA subsidy extension lessens 2026 premium cuts: CBO
Sep 18, 2025 3:32pm
163 bipartisan lawmakers tell HHS to scrap 340B rebate pilot
Sep 10, 2025 2:10pm
Republicans tout CBO study on ACA subsidies, immigrant sign-ups
Sep 3, 2025 3:10pm
CBO: Tax bill may lead to $500B in Medicare cuts in next decade
Aug 18, 2025 3:45pm
CMS mum on coverage losses under Trump plan but rejects CBO
Jun 25, 2025 5:00am
